Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver Transplantatio

Recruiting

• Conditions: C22.0; Liver cell carcinoma

• Registration Number: DRKS00027969
• Lead Sponsor: MU München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients who underwent liver transplantation in our center with a diagnosis of HCC.

Exclusion Criteria

missing data of the transplantation
no proven diagnosis of HCC

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The goal is the best possible identification of HCC patients who experience a high probability of HCC recurrence after liver transplantation

Secondary Outcome Measures

Name	Time	Method
Preoperative CT and MRI data sets should therefore be analyzed and evaluated using a multi-stage approach.